LNA LNA Santé SA

27.75USD25.30 EUR · EPA-1.17%Mkt Cap: 285.70M USDP/E: 10.24

LNA Santé SA engages in the management and operation of healthcare facilities and medical residences for able-bodied, semi-dependent, or dependent elderly people in France. The company operates medical care and rehabilit…

Key Statistics

Company
Market Cap285.70M USD
Enterprise Value1.23B USD
Revenue (TTM)1.04B USD
Gross Profit878.53M USD
Net Income (TTM)26.48M USD
Revenue/Share101.42 USD
Last Price27.75 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees8.8K
CountryFR
SectorHealthcare
IndustryMedical Care Facilities
ISINFR0004170017
Valuation
P/E (Trailing)10.24
P/E (Forward)7.66
PEG1.16
EV/EBITDA11.28
EV/Revenue1.18
P/S0.27
P/B0.78
EPS (TTM)2.71 USD
EPS (Forward)3.62 USD
52W Range
24.1323% of range40.03
52W High40.03 USD
52W Low24.13 USD
Profitability
Gross Margin87.76%
Oper. Margin7.92%
EBITDA Margin10.45%
Profit Margin2.65%
ROE7.31%
ROA1.51%
ROIC4.20%
ROCE6.58%
Growth
Revenue Growth8.40%
Earnings Growth10.20%
Cash Flow & Leverage
Operating CF109.04M USD
CapEx (TTM)14.30M USD
FCF Margin9.89%
FCF Yield36.07%
Net Debt933.35M USD
Net Debt/EBITDA8.57
Net Debt/FCF9.06
Balance Sheet
Debt/Equity2.74
Current Ratio0.87
Quick Ratio0.44
Book Value/Sh35.53 USD
Cash/Share9.53 USD
Dividends
Fwd Div Rate1.04 USD
Trail. Div Rate1.04 USD
Div. Yield3.63%
5Y Avg Yield1.48%
Payout Ratio26.36%
Ex-Div DateJul 8, 2026
Pay Date—
Analyst Consensus
Rating1.5 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)45.08 USD
Upside (mean)+62.5%
Target Range39.48 USD – 51.55 USD
39.48+62.5% to mean51.55
# Analysts4
Ownership
Shares Out.10.30M
Float6.85M
Insiders55.22%
Institutions10.96%
Technical
SMA 5028.78 (-3.6%)
SMA 20032.68 (-15.1%)
Beta0.56
S&P 52W Chg12.00%
Avg Vol (30d)7.70K
Avg Vol (10d)6.07K
Technical Indicators
RSI (14)48.0
MACD0.1388
MACD Signal-0.0446
MACD Hist.+0.1834
BB Upper29.99 USD
BB Middle27.53 USD
BB Lower25.07 USD
BB Width17.86%
ATR (14)0.9000 USD
Vol Ratio (20d)0.54x

About LNA Santé (EPA: LNA)

›

LNA Santé (EPA: LNA) is listed on Euronext Paris, where its shares trade in EUR. It belongs to the Medical Care Facilities industry, part of the Healthcare sector, and reports about 8,777 employees.

The shares were at 25.30 EUR on 19 November 2026, up 9.5% over 52 weeks. Its 52-week range is 22.00 EUR to 36.50 EUR: the price is 30.7% below the high and 15.0% above the low.

At a market capitalisation of 260.49M EUR, it trades at 10.2 times trailing earnings and 7.7 times forward earnings. The median trailing P/E of its 18 largest Medical Care Facilities peers is 23.7, a discount of 57% for LNA. It pays a dividend yielding 3.63% (it pays out 26% of its earnings), against a median of 0.75% among the dividend payers in that peer group.

LNA Santé reports return on equity of 7.3%, an operating margin of 7.9% and revenue up 8.4% year over year.

Its debt exceeds its cash by 850.98M EUR, a debt-to-equity ratio of 2.74. Its Piotroski F-score is 8 out of 9, a strong reading of its financial health. 4 analysts cover the stock, with an average rating of Buy; their mean price target of 41.10 EUR is 62.5% above the current price.